Find out how NICE develops guidance through evidence reviews, expert committees, stakeholder consultations, and regular updates to ensure high-quality health and social care.
What NICE does
We produce useful and usable guidance for the NHS and wider health and care system.
We help practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Guidance
Our guidance takes many forms: NICE guidelines (clinical, social care, public health, medicines practice), technology appraisals, interventional procedures, medical technologies, diagnostics and highly specialised technologies.
We have a library of over 200 quality standards and a single menu of indicators. They can be used to help define and measure quality in health, public health and social care.
Evidence summaries are advice rather than formal guidance. They help healthcare professionals make decisions and support the development and updating of local formularies.
Digital health
We can help you to build the evidence you need to achieve market access and improve lives. Our aim is to improve patient access to the best digital health innovations.
Research
Learn how we are to staying one step ahead of innovative new health technologies and treatments, policy developments and changes in health and social care delivery.
How we work with researchers, funders, charities and policy organisations to achieve high quality, impactful research.
Our projects and partnerships help us to keep improving how NICE works. They also help us anticipate and adapt to policy developments, including changes in health and social care delivery.
Our Health Technology Assessment Innovation Laboratory (HTA Lab) enables us to develop creative solutions to complex problems in health technology assessment.
Our healthcare podcast covers a range of topics related to healthcare and medical guidelines.
Commercial agreements
We help to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.
A patient access scheme is a way to make expensive medicines more affordable for patients and the healthcare system.
Managed access gives people faster access to promising new treatments.